![]() | |
Clinical data | |
---|---|
Other names | ECYPLA |
Legal status | |
Legal status |
|
Identifiers | |
| |
Chemical and physical data | |
Formula | C21H25N3O |
Molar mass | 335.451 g·mol−1 |
3D model (JSmol) | |
| |
|
ECPLA (N-ethyl-N-cyclopropyllysergamide) is an analogoflysergic acid diethylamide (LSD) developed by Synex Synthetics. In studies in mice, it was found to have approximately 40% the potency of LSD.[2][3]
| |
---|---|
Lysergic acid derivatives |
|
Psychedelic lysergamides |
|
Clavines |
|
Other ergolines |
|
Natural sources |
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui) |
![]() | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |